|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 9/10 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61K 31/137 | (2006.01) |
| (11) | Number of the document | 3076971 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14867191.0 |
| Date of filing the European patent application | 2014-12-04 | |
| (97) | Date of publication of the European application | 2016-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-20 |
| (46) | Date of publication of the claims translation | 2022-02-10 |
| (86) | Number | PCT/US2014/068527 |
| Date | 2014-12-04 |
| (87) | Number | WO 2015/085044 |
| Date | 2015-06-11 |
| (30) | Number | Date | Country code |
| 201361913216 P | 2013-12-06 | US | |
| 201361914938 P | 2013-12-11 | US | |
| 201461984580 P | 2014-04-25 | US | |
| 201414322810 | 2014-07-02 | US |
| (72) |
KLASSEN, Preston , US
TAYLOR, Kristin , US
|
| (73) |
Nalpropion Pharmaceuticals LLC ,
155 Franklin Rd, Suite 450, Brentwood, TN 37027,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti sumažinti didžiąsias širdies ir kraujagyslių komplikacijas |
| COMPOSITIONS AND METHODS FOR REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS |
| Payment date | Validity (years) | Amount | |
| 2024-11-20 | 11 | 289.00 EUR |
| 2025-12-04 |